# Immunotropic Effects of Steroid Hormone Medicines in Combination with Plasma-Treated Solution in Women of a Reproductive Age and Postmenopausal Women

**Authors:** Tatyana Ivanovna Pavlik, Nadejda Maximovna Kostukova, Darya Andreevna Razvolyaeva, Evgeny Mikhaylovich Konchekov, Leonid Viktorovich Kolik, Namik Guseinaga-ogly Gusein-zade, Nikolai L’vovich Shimanovskii

PMC · DOI: 10.3390/medsci13040209 · Medical Sciences · 2025-09-24

## TL;DR

This study examines how steroid hormone medicines and plasma-treated solutions affect inflammation in reproductive-age and postmenopausal women.

## Contribution

The study reveals how combining steroid hormones and plasma-treated solutions modulates immune responses differently in two age groups of women.

## Key findings

- PTS reduced IL-6 and RONS production by 50% and increased IL-10 production 2-fold in postmenopausal women.
- PTS and steroid hormones together suppressed cytokine and oxidant activity in both groups.
- Progestins and dexamethasone showed distinct anti-inflammatory effects depending on the age group.

## Abstract

Background: Steroidal glucocorticoid and gestagenic drugs and cold plasma-treated solutions (PTSs) are known to exert anti-inflammatory effects by influencing the production of a number of cytokines. The aim of this work was to test their independent and combined effects exerted on the production of cytokines IL-1, IL-6, TNF-α, TGF-β, and IL-10 and reactive oxygen and nitrogen species (RONS) by leukocytes in women of a reproductive age and postmenopausal women. Methods: ELISA and chemiluminescence methods were used for this purpose. Results: PTS reduced IL-6 and RONS production by 50% and increased IL-10 production 2-fold in postmenopausal women, and it reduced IL-6 production by 80% and RONS production by 50% in women of reproductive age. When PTS and steroid hormonal drugs are used together, there is a general suppression of cytokine and oxidant activity. Conclusions: PTS reduces the production of inflammatory factors by leukocytes and stimulates the production of anti-inflammatory factors, more so in postmenopausal women. Progestins showed greater suppression of pro-inflammatory cytokine and RONS formation and stimulation of anti-inflammatory cytokines for women of reproductive age and dexamethasone showed such results for postmenopausal women.

## Linked entities

- **Proteins:** IL1A (interleukin 1 alpha), IL6 (interleukin 6), TNF (tumor necrosis factor), TGFB1 (transforming growth factor beta 1), IL10 (interleukin 10)
- **Chemicals:** dexamethasone (PubChem CID 5743)

## Full-text entities

- **Genes:** IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** PTS (MESH:C535325), inflammatory (MESH:D007249)
- **Chemicals:** Steroid Hormone (MESH:D013256), PTS (-), dexamethasone (MESH:D003907)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12551079/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12551079/full.md

## References

52 references — full list in the complete paper: https://tomesphere.com/paper/PMC12551079/full.md

---
Source: https://tomesphere.com/paper/PMC12551079